About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 440 record(s)
Req # A-2020-000310
Adverse Reaction Report (AER). Report number: 000718930.Organization: Health Canada
July 2020
Req # A-2020-000324
Adverse Reaction Report (AER) for Intuniv XR. Report number: 000732758.Organization: Health Canada
July 2020
Req # A-2020-000327
Adverse Reaction Report (AER) for Mesalazine. Report numbers: E2B_02818518, E2B_02871990, E2B_02903320, E2B_02903659.Organization: Health Canada
July 2020
Req # A-2020-000331
Adverse Reaction Report (AER) for GAMMAGARD LIQUID. Report numbers: 000732489, 000733136, 000733265, E2B_02891437, 000732400, 000732471, 000732691, 000734265, 000734399, 000735637, 000734267, 000734378, 000734458, 000735152, 000735160, 000735210.Organization: Health Canada
July 2020
Req # A-2020-000344
Adverse Reaction Report (AER) for BLUE V. Report number: E2B_03021287.Organization: Health Canada
July 2020
Req # A-2020-000353
Adverse Reaction Report (AER) for DOCUSATE SODIUM. Report number: 728535.Organization: Health Canada
July 2020
Req # A-2020-000355
Adverse Reaction Report (AER) for LEFLUNOMIDE. Report numbers: E2B_02951932, E2B_02956171, E2B_02829935, E2B_02078745, E2B_02965004, E2B_02968275, E2B_02968785, E2B_02448679, E2B_02865025, E2B_02830324, E2B_02830332, E2B_02830372, E2B_02830412, E2B_02830674, E2B_02830918, E2B_02832231.Organization: Health Canada
July 2020
Req # A-2020-000356
Adverse Reaction Report (AER) for INSULIN GLULISINE. Report number: 000728734.Organization: Health Canada
July 2020
Req # A-2020-000359
Adverse Reaction Report (AER) for PSEUDOEPHEDRINE HYDROCHLORIDE. Report number: E2B_02563837.Organization: Health Canada
July 2020
Req # A-2020-000361
Adverse Reaction Report (AER) for METOLAZONE. Report number: E2B_02690659.Organization: Health Canada
July 2020